These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 19427605

  • 1. Combined secondary prevention after hospitalization for myocardial infarction in France: analysis from a large administrative database.
    Tuppin P, Neumann A, Danchin N, Weill A, Ricordeau P, de Peretti C, Allemand H.
    Arch Cardiovasc Dis; 2009 Apr; 102(4):279-92. PubMed ID: 19427605
    [Abstract] [Full Text] [Related]

  • 2. Pharmacological treatment after acute myocardial infarction from 2001 to 2006: a survey in Italian primary care.
    Filippi A, D'Ambrosio G, Giustini SE, Pecchioli S, Mazzaglia G, Cricelli C.
    J Cardiovasc Med (Hagerstown); 2009 Sep; 10(9):714-8. PubMed ID: 19465867
    [Abstract] [Full Text] [Related]

  • 3. Secondary medical prevention among Danish patients hospitalised with either peripheral arterial disease or myocardial infarction.
    Gasse C, Jacobsen J, Larsen AC, Schmidt EB, Johannesen NL, Videbaek J, Sørensen HT, Johnsen SP.
    Eur J Vasc Endovasc Surg; 2008 Jan; 35(1):51-8. PubMed ID: 17923426
    [Abstract] [Full Text] [Related]

  • 4. Evidence-based pharmacotherapy after myocardial infarction in France: adherence-associated factors and relationship with 30-month mortality and rehospitalization.
    Tuppin P, Neumann A, Danchin N, de Peretti C, Weill A, Ricordeau P, Allemand H.
    Arch Cardiovasc Dis; 2010 Jan; 103(6-7):363-75. PubMed ID: 20800800
    [Abstract] [Full Text] [Related]

  • 5. Treatment with statins after acute myocardial infarction in patients >or=80 years: underuse despite general acceptance of drug therapy for secondary prevention.
    Kvan E, Pettersen KI, Landmark K, Reikvam A, INPHARM study investigators.
    Pharmacoepidemiol Drug Saf; 2006 Apr; 15(4):261-7. PubMed ID: 16315337
    [Abstract] [Full Text] [Related]

  • 6. Re: Secondary medical prevention in patients with peripheral arterial disease.
    Schouten O, Welten GM, Bax JJ, Poldermans D.
    Eur J Vasc Endovasc Surg; 2008 Jan; 35(1):59-60. PubMed ID: 17719805
    [No Abstract] [Full Text] [Related]

  • 7. Tackling inequalities: are secondary prevention therapies for reducing post-infarction mortality used without disparities?
    Buja A, Boemo DG, Furlan P, Bertoncello C, Casale P, Baldovin T, Marcolongo A, Baldo V.
    Eur J Prev Cardiol; 2014 Feb; 21(2):222-30. PubMed ID: 22997352
    [Abstract] [Full Text] [Related]

  • 8. Patterns of statin prescription in acute myocardial infarction: the French registry of Acute ST-elevation or non-ST-elevation Myocardial Infarction (FAST-MI).
    Ferrières J, Bataille V, Leclercq F, Geslin P, Ruidavets JB, Grollier G, Bernard P, Cambou JP, Simon T, Danchin N.
    Atherosclerosis; 2009 Jun; 204(2):491-6. PubMed ID: 19004441
    [Abstract] [Full Text] [Related]

  • 9. Age and sex inequalities in the prescription of evidence-based pharmacological therapy following an acute coronary syndrome in Portugal: the EURHOBOP study.
    Pereira M, Araújo C, Dias P, Lunet N, Subirana I, Marrugat J, Capewell S, Bennett K, Azevedo A.
    Eur J Prev Cardiol; 2014 Nov; 21(11):1401-8. PubMed ID: 23787795
    [Abstract] [Full Text] [Related]

  • 10. Secondary prevention following coronary artery bypass grafting has improved but remains sub-optimal: the need for targeted follow-up.
    Turley AJ, Roberts AP, Morley R, Thornley AR, Owens WA, de Belder MA.
    Interact Cardiovasc Thorac Surg; 2008 Apr; 7(2):231-4. PubMed ID: 18234766
    [Abstract] [Full Text] [Related]

  • 11. Cardioprotective medication use after acute myocardial infarction in kidney transplant recipients.
    Lentine KL, Villines TC, Xiao H, Schnitzler MA, Brennan DC, Abbott KC, Hauptman PJ.
    Transplantation; 2011 May 27; 91(10):1120-6. PubMed ID: 21427631
    [Abstract] [Full Text] [Related]

  • 12. Drug prescriptions and referral to cardiac rehabilitation after acute coronary events: comparison between men and women in the French PREVENIR Survey.
    Bongard V, Grenier O, Ferrières J, Danchin N, Cantet C, Amelineau E, Cambou JP.
    Int J Cardiol; 2004 Feb 27; 93(2-3):217-23. PubMed ID: 14975550
    [Abstract] [Full Text] [Related]

  • 13. A retrospective, observational cohort analysis of a nationwide database to compare heart failure prescriptions and related health care utilization before and after publication of updated treatment guidelines in the United States.
    Shafazand S, Yang Y, Amore E, O'Neal W, Brixner D.
    Clin Ther; 2010 Aug 27; 32(9):1642-50. PubMed ID: 20974322
    [Abstract] [Full Text] [Related]

  • 14. Trends in the use of antihypertensive drugs by outpatients with diabetes in Taiwan, 1997-2003.
    Chiang CW, Chen CY, Chiu HF, Wu HL, Yang CY.
    Pharmacoepidemiol Drug Saf; 2007 Apr 27; 16(4):412-21. PubMed ID: 17252613
    [Abstract] [Full Text] [Related]

  • 15. Underuse of ACE inhibitors and angiotensin II receptor blockers in elderly patients with diabetes.
    Winkelmayer WC, Fischer MA, Schneeweiss S, Wang PS, Levin R, Avorn J.
    Am J Kidney Dis; 2005 Dec 27; 46(6):1080-7. PubMed ID: 16310574
    [Abstract] [Full Text] [Related]

  • 16. Ten-year trends of cardiovascular drug use after myocardial infarction among community-dwelling persons > or =65 years of age.
    Setoguchi S, Glynn RJ, Avorn J, Levin R, Winkelmayer WC.
    Am J Cardiol; 2007 Oct 01; 100(7):1061-7. PubMed ID: 17884362
    [Abstract] [Full Text] [Related]

  • 17. Parabolas of medication use and discontinuation after myocardial infarction--are we closing the treatment gap?
    Hudson M, Richard H, Pilote L.
    Pharmacoepidemiol Drug Saf; 2007 Jul 01; 16(7):773-85. PubMed ID: 17486661
    [Abstract] [Full Text] [Related]

  • 18. A cohort study of therapeutic prescriptions after the end of phytotherapy drug reimbursement by French Social Security.
    Riou França L, Vidal C, Bourechak N, Jeunne PL, Deville GS, Massol J.
    Pharmacoepidemiol Drug Saf; 2013 Jul 01; 22(7):760-8. PubMed ID: 23208799
    [Abstract] [Full Text] [Related]

  • 19. Hospital variation in use of secondary preventive medicine after discharge for first acute myocardial infarction during 1995-2004.
    Rasmussen S, Abildstrom SZ, Rasmussen JN, Gislason GH, Schramm TK, Folke F, Køber L, Torp-Pedersen C, Madsen M.
    Med Care; 2008 Jan 01; 46(1):70-7. PubMed ID: 18162858
    [Abstract] [Full Text] [Related]

  • 20. [Cracovian Program for Secondary Prevention of Ischaemic Heart Disease. The quality of care in the field of secondary prevention of ischaemic heart disease depends on where patients are treated in the postdischarge period].
    Jankowski P, Kawecka-Jaszcz K, Pajak A.
    Przegl Lek; 2001 Jan 01; 58 Suppl 6():21-5. PubMed ID: 11873737
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.